Rigel Pharmaceuticals Insider Trades
NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 3 · $305.87K
- Shares bought / sold
- 0 / 9.00K
- Net activity
- Net selling $305,865
Rigel Pharmaceuticals insider activity
Over the last 12 months, Rigel Pharmaceuticals insiders reported 45 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $305,865 worth of stock, for net insider selling of $305,865. The largest seller was Ali-Jackson Kamil, with $160,425 in reported sales.
The most recent filing shows Schorno Dean L (EVP & Chief Financial Officer) reporting a transaction in 694 shares at $12.70 on Sep 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RIGL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RIGL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 2, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 1,286 | $31.12K | Form 4 |
| Sep 2, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 2,000 | $48.40K | Form 4 |
| Sep 2, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 620 | $11.59K | Form 4 |
| Sep 2, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 694 | $8.81K | Form 4 |
| Sep 1, 2026 | Furey Raymond J.EVP, GC, CCO & Corp Sec | Tax withholding | 877 | $41.66K | Form 4 |
| Sep 1, 2026 | Schorno Dean LEVP & Chief Financial Officer | Tax withholding | 928 | $44.08K | Form 4 |
| Sep 1, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 2,424 | $115.14K | Form 4 |
| Sep 1, 2026 | Santos David AEVP, Chief Commercial Officer | Tax withholding | 874 | $41.52K | Form 4 |
| Jul 8, 2026 | HANNAH ALISON L.EVP, Chief Medical Officer | Award | 24,400 | — | Form 4 |
| Jun 22, 2026 | Ali-Jackson KamilDirector | Sale | 2,500 | $87.50K | Form 4 |
| Jun 1, 2026 | Furey Raymond J.EVP, GC, CCO & Corp Sec | Tax withholding | 877 | $26.19K | Form 4 |
| Jun 1, 2026 | Santos David AEVP, Chief Commercial Officer | Tax withholding | 874 | $26.10K | Form 4 |
| Jun 1, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 2,424 | $72.38K | Form 4 |
| Jun 1, 2026 | Rojkjaer LisaEVP, Chief Medical Officer | Tax withholding | 850 | $25.38K | Form 4 |
| Jun 1, 2026 | Schorno Dean LEVP & Chief Financial Officer | Tax withholding | 928 | $27.71K | Form 4 |
| Jun 1, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 2,181 | $27.70K | Form 4 |
| Jun 1, 2026 | Schorno Dean LEVP & Chief Financial Officer | Option exercise | 1,200 | $22.44K | Form 4 |
| May 26, 2026 | Ali-Jackson KamilDirector | Sale | 2,500 | $72.92K | Form 4 |
| May 15, 2026 | Ali-Jackson KamilDirector | Award | 5,750 | — | Form 4 |
| May 15, 2026 | HANNAH ALISON L.Director | Award | 5,750 | — | Form 4 |
| May 15, 2026 | MILLER MICHAEL PATRICKDirector | Award | 5,750 | — | Form 4 |
| May 15, 2026 | Frohlich Mark WDirector | Award | 5,750 | — | Form 4 |
| May 15, 2026 | LAPOINTE ANTHONY GREGGDirector | Award | 5,750 | — | Form 4 |
| May 15, 2026 | MOOS WALTER HDirector | Award | 5,750 | — | Form 4 |
| May 15, 2026 | Wasman JaneDirector | Award | 5,750 | — | Form 4 |
| Feb 20, 2026 | MOOS WALTER HDirector | Sale | 4,000 | $145.44K | Form 4 |
| Feb 20, 2026 | MOOS WALTER HDirector | Option exercise | 4,000 | $96.00K | Form 4 |
| Feb 17, 2026 | Schorno Dean LEVP & Chief Financial Officer | Award | 20,636 | — | Form 4 |
| Feb 17, 2026 | Furey Raymond J.EVP, GC, CCO & Corp Sec | Award | 19,497 | — | Form 4 |
| Feb 17, 2026 | Santos David AEVP, Chief Commercial Officer | Award | 19,430 | — | Form 4 |
| Feb 17, 2026 | Rojkjaer LisaEVP, Chief Medical Officer | Award | 18,894 | — | Form 4 |
| Feb 17, 2026 | RODRIGUEZ RAUL RCEO, President | Award | 53,915 | — | Form 4 |
| Feb 10, 2026 | Rojkjaer LisaEVP, Chief Medical Officer | Tax withholding | 3,758 | $130.10K | Form 4 |
| Feb 10, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 7,607 | $263.35K | Form 4 |
| Feb 10, 2026 | Santos David AEVP, Chief Commercial Officer | Tax withholding | 3,546 | $122.76K | Form 4 |
| Feb 10, 2026 | Furey Raymond J.EVP, GC, CCO & Corp Sec | Tax withholding | 3,546 | $122.76K | Form 4 |
| Feb 10, 2026 | Schorno Dean LEVP & Chief Financial Officer | Tax withholding | 3,546 | $122.76K | Form 4 |
| Feb 2, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 14,110 | $508.10K | Form 4 |
| Feb 2, 2026 | Santos David AEVP, Chief Commercial Officer | Tax withholding | 5,718 | $205.91K | Form 4 |
| Feb 2, 2026 | Furey Raymond J.EVP, GC, CCO & Corp Sec | Tax withholding | 3,968 | $142.89K | Form 4 |
| Feb 2, 2026 | Schorno Dean LEVP & Chief Financial Officer | Tax withholding | 5,488 | $197.62K | Form 4 |
| Jan 26, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 35,424 | $1.31M | Form 4 |
| Jan 26, 2026 | RODRIGUEZ RAUL RCEO, President | Option exercise | 40,000 | $1.10M | Form 4 |
| Jan 26, 2026 | RODRIGUEZ RAUL RCEO, President | Tax withholding | 35,211 | $1.30M | Form 4 |
| Jan 26, 2026 | RODRIGUEZ RAUL RCEO, President | Option exercise | 40,000 | $1.10M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4